FDA recall record

OptiWize Health OptiWize Collagen Plus 320 count bottle recall — FDA H-0442-2026

The firm initiated a voluntary recall after NSF testing showed that labeled ingredient quantities did not align with analytical test results, manganese…

Class IIIclassification
H-0442-2026official record ID
Feb 11, 2026report date

Recall record at a glance

Official recordH-0442-2026
CategoryFood Recalls
ClassificationClass III
FDA record statusCompleted
Recalling firmOptiwize Inc.
Report dateFeb 11, 2026
Recall initiation dateSep 23, 2025
Quantity78 units
LocationBuda, TX, United States

Official product description

OptiWize Health OptiWize Collagen Plus 320 count bottle; White bottle with black lid.

Why the product was recalled

The firm initiated a voluntary recall after NSF testing showed that labeled ingredient quantities did not align with analytical test results, manganese level was below label quantity.

Distribution information

Nationwide via Amazon distribution

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: E-Mail.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.